Advancements in upstream CLD for enhanced biotherapeutics production
Drug Discovery World
NOVEMBER 27, 2023
In addition, it has stimulated increased collaboration among drug developers, technology providers, supply chain organisations, and regulators. Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production. Budge JD, Knight TJ, Povey J, et al.
Let's personalize your content